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A investigação fitoquímica dos frutos maduros de Solanum caavurana Vell. (Solanaceae) 
forneceu um novo alcaloide esteroidal do tipo espirosolano, caavuranamida, juntamente com os 
alcaloides 4-tomatiden-3-ona e 5α-tomatidan-3-ona. Suas estruturas foram elucidadas através 
de métodos espectroscópicos. As atividades antiproliferativa e antimicrobiana para o extrato 
etanólico e subfrações provenientes de partição e de extração ácido-base foram investigadas. A 
caavuranamida  apresentou atividade antibacteriana similar ao controle positivo cloranfenicol 
contra Rhodococcus equi.
Phytochemical investigation of the ripe fruits of Solanum caavurana Vell. (Solanaceae) 
afforded a novel steroidal alkaloid with spirosolane-type skeleton, named as caavuranamide, 
together with the alkaloids 4-tomatiden-3-one and 5α-tomatidan-3-one. Their structures were 
elucidated on the basis of spectroscopic methods. The antiproliferative and antimicrobial activities 
for the ethanolic extract, sub-fractions obtained from partition and acid-base treatment were also 
evaluated. Caavuranamide  showed antibacterial activity similar to the chloramphenicol positive 
control against Rhodococcus equi.
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Introduction
The genus Solanum is the most representative of 
Solanaceae family, comprising about 1400 species1 mainly 
distributed in tropical and subtropical regions of Americas, 
Africa and Australia.2 In Brazil, about 350 Solanum species 
have been identified, many of them endemic.3
Solanum caavurana Vell. grows as a bush or a small 
tree with ca. 5 m high, and is widely distributed in 
Brazil (in Ceará, Bahia, Mato Grosso do Sul, Paraná and 
Santa Catarina States), occurring in Paraguay and 
Argentina as well. It is popularly known as ‘laranjinha do 
mato’, ‘jurubebarana’2 or ‘jurubeba-branca’, being used 
in folk medicine to treat anemia, liver disorders and as 
digestive as well.1 Although phytochemical studies on 
Solanum species resulted in the isolation of a great variety 
of steroidal alkaloids and glycoalkaloids,4,5 to the best 
of our knowledge, the only report found for this species 
was an unsuccessful search for solasodine in its unripe 
fruits.6
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Here, we report the identification of a novel steroidal 
alkaloid, named as caavuranamide (1), along with the 
known 4-tomatiden-3-one (2) and 5α-tomatidan-3-one (3), 
isolated from the ethanolic extracts of the ripe fruits of 
Solanum caavurana Vell.
Experimental
General experimental procedures
Melting point (mp) was determined on a Quimis 
Q-340S23 micromelting point apparatus. IR spectra were 
acquired on a BIORAD FTS-3500, Fourier transform 
infrared (FTIR) equipment. Optical rotation was measured 
by using a Rudolph Research (Flanders, New Jersey) 
Autopol III automatic spectropolarimeter. Nuclear magnetic 
resonance (NMR) data were recorded at 293 K in CDCl3 
on a Varian Inova 500 operating at 11.7 T, observing 1H 
at 500 MHz and 13C at 125 MHz. Chemical shifts (d) are 
given in ppm relative to TMS (tetramethylsilane) (d 0.00) 
as the internal standard. The electron spray ionization mass 
spectra (HRESIMS and HRESIMS/MS) were acquired in 
positive ion mode and recorded on a quadrupole-time of 
flight instrument (UltrOTOF-Q, Bruker Daltonics, Billerica, 
MA). The conditions were: capillary voltage of 3400 V, 
dry gas temperature of 180 °C, dry gas flow of 4 L h-1, 
nitrogen as nebulizer gas and 10 mmol L-1 NaTFA (sodium 
trifluoroacetate) was used as the standard for internal and 
external calibration. For tandem mass spectrometry analysis 
(ESIMS/MS), nitrogen was used as the collision gas. Silica 
gel 60 (70-230 mesh) was used for column chromatography, 
aluminum precoated silica-gel plates (60 F254 Merck, 
0.25 mm) were used for analytical thin layer chromatography 
(TLC), and glass precoated silica-gel plates (60 PF254 Merck, 
1 mm) were used for preparative TLC. The spots were 
detected by spraying with Dragendorff’s or p-anisaldehyde 
reagents, followed by heating.
Plant material
The ripe fruits of S. caavurana were collected in the Parque 
Estadual de Vila Rica do Espírito SAnto (PEVR: 23°55' S, 
51°57' W), in the municipal district of Fênix (Paraná State, 
Brazil), in January 2004. A voucher specimen (No. 28280) was 
deposited at the Herbarium of the Botany Department from 
Universidade Federal do Paraná (UPCB-UFPR).
Extraction and isolation
The ripe fruits of S. caavurana were dried at 40 °C, 
crushed, pulverized (180.5 g) and successively extracted at 
room temperature with petrol (30-60 °C) (5 days) and ethanol 
(5 days), with the solvent removed every 24 h. The ethanolic 
extract was submitted to liquid-liquid partition with CH2Cl2 
followed by n-butanol (n-but). Removal of the solvents under 
reduced pressure furnished 2.6 and 3.0 g of CH2Cl2 and 
n-but fractions, respectively, both revealing positive TLC 
Dragendorff’s test. CH2Cl2 fraction was dissolved in 3% 
aqueous HCl and the acid liquid phase then extracted with 
CHCl3 (3 × 20 mL). The organic fractions were combined, 
dried with anhydrous Na2SO4 and concentrated under reduced 
pressure to obtain the neutral CHCl3 fraction (947.0 mg). 
The remaining aqueous acid solution was adjusted to 
pH 10-12 with 37% aqueous NH4OH followed by extraction 
with CHCl3 (3 × 20 mL). The resulting organic fractions 
were treated as previously described to yield an alkaloid 
residue (122.5 mg), which was purified by preparative 
TLC eluted with EtOAc-MeOH 90:10 to yield 1 (6.6 mg). 
The neutral CHCl3 fraction (947.0 mg) was subjected to 
silica-gel column chromatography, with gradient elution of 
CH2Cl2/EtOAc from 100:0 to 25:75, EtOAc/MeOH from 
100:0 to 90:10 and MeOH, affording a total of 184 fractions 
(20 mL each), which were assembled in 18 subfractions 
according to their composition on TLC. Subfractions 10 
(34.2 mg) and 9 (50.7 mg) were purified by preparative TLC 
eluted with CH2Cl2/MeOH 90:10 and CH2Cl2/MeOH 95:5, 
respectively, to yield 2 (5.0 mg) and 3 (2.5 mg).
Caavuranamide (1)
Yellowish powder; 1H and 13C NMR data given in Table 1; 
mp 115-117 ºC; [α]D25 + 6.3 (CHCl3; c 0.0027); IR (KBr) 
νmax/cm-1 3429, 2930, 2852, 2362, 2341, 1656, 1543, 1456, 
1383, 1264, 1037, 973, 872, 750 and 668; HRESIMS m/z 
443.3705 [M + H]+ (calcd. for C28H46N2O2 + H+, 443.6770).
4-Tomatiden-3-one (2)
Light-yellow amorphous powder; 1H and 13C NMR data 
given in Table 1; HRESIMS m/z 412.3320 [M + H]+ (calcd. 
for C27H41NO2 + H+, 412.6338).
5α-Tomatidan-3-one (3)
Yellow amorphous powder; 1H and 13C NMR data given 
in Table 1; HRESIMS m/z 414.3443 [M + H]+ (calcd. for 
C27H43NO2 + H+, 414.6496).
In vitro antimicrobial activity
The antimicrobial activity of the crude extracts and 
fractions were tested against nine microorganisms 
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(Bacillus subtilis ATCC 6051, Escherichia coli ATCC 11775, 
Enterococcus faecium CCT 5079, Micrococcus luteus 
ATCC 4698, Pseudomonas aeruginosa ATCC 13388, 
Rhodococcus equi ATCC 25729, Staphylococcus aureus 
ATCC 6538, Salmonella choleraesuis ATCC 10708 and 
Staphylococcus epidermides ATCC 12228). Compound 1 was 
tested against E. coli, R. equi, S. aureus, S. epidermides and 
S. choleraesuis.
The bacteria strains were subcultured overnight at 
36 °C in Nutrient Agar (Merck). Inoculum for the assays 
were prepared by diluting a scraped cell mass in 0.85% 
NaCl solution, adjusted to McFarland scale 0.5 and 
confirmed by spectrophotometer reading at 580 nm. Cell 
suspensions were finally diluted to 104 cfu mL-1 for use in 
the activity assays. Minimal inhibitory concentration (MIC) 
tests were carried out according to Eloff,7 using Müller-
Hinton broth on a tissue-culture test plate (96 wells). 
The stock solutions of crude extracts and fractions were 
diluted and transferred into the first well, and serial 
dilutions were made, so that concentrations in the range 
of 1.000-0.015 mg mL-1 were obtained. Chloramphenicol 
(Merck) was used as the reference antibiotic control in 
the range of 0.250-0.002 mg mL-1. The inoculum was 
added to all wells, and the plates were incubated at 36 °C 
for 48 h. Each concentration was screened in triplicate. 
Antimicrobial activity was detected by adding 20 µL of 
0.5% TTC (triphenyltetrazolium chloride, Merck) aqueous 
solution. MIC was defined as the lowest concentration of 
the sample that inhibited visible growth, as indicated by 
TTC staining (dead cells are not stained by TTC).
In vitro antiproliferative activity assay
Human tumor cell lines U251 (glioma, CNS), UACC-62 
(melanoma), MCF-7 (breast), NCI-H460 (lung, non-small 
cells), OVCAR-03 (ovarian), HT-29 (colon), 786-0 
(renal), NCI-ADR/RES (ovarian expressing phenotype 
multiple drugs resistance) and K562 (leukemia) were 
kindly provided by National Cancer Institute (NCI, U. S. 
Department of Health and Human Services). Stock cultures 
were grown in medium containing 5 mL RPMI 1640 
(Gibco-BRL) supplemented with 5% fetal bovine serum. 
Peniciline:streptomicine (1000 µg mL-1:1000 UI mL-1, 
1 mL L-1) was added to experimental cultures. Cells 
in 96 well plates (100 µL cells per well) were exposed 
to sample concentrations in DMSO/RPMI (0.25, 2.5, 
25 and 250 µg mL-1) at 37 °C, 5% of CO2 in air for 48 h. 
Final DMSO concentration did not affect cell viability. 
Afterwards, cells were fixed with 50% trichloroacetic 
acid and cell proliferation determined by spectrophotometric 
quantification (540 nm) of cellular protein content using 
sulforhodamine B assay. Using the concentration-response 
curve for each cell line, TGI (concentration that produces 
total growth inhibition or cytostatic effect) was determined 
through non-linear regression analysis using software 
ORIGIN 7.5 (OriginLab Corporation).8
Results and Discussion
The ethanolic extract from the ripe fruits of Solanum 
caavurana afforded steroidal alkaloids 1-3 (Figure 1).
Caavuranamide (1) was isolated as a yellowish 
powder and gave a positive Dragendorff reagent test. 
Its molecular formula C28H46N2O2 was calculated from 
the HRESIMS quasi-molecular ion peak [H + H]+ at 
m/z 443.3705. The HRESIMS/MS revealed two fragments 
at m/z 255.2139 and 300.2349 corresponding to a difference 
of 45.0210 Da, suggesting the loss of a formamide group 
(H2N-CHO, calcd. 45.041 Da).
The decoupled 13C NMR spectrum of 1 (Table 1) 
displayed 28 carbon signals, mainly in the sp3 C field 
characteristic of steroidal alkaloids,9 whereas DEPT-135 
(distortionless enhancement by polarization transfer) 
analysis aided to attribute the presence of four methyl groups, 
one carbonyl (dC 160.3), eleven methylenes, nine methines 
(including one oximethine) and three quaternary carbons.
The carbinolic hydrogen H-16 (dH 4.14) was correlated 
with C-16 (dC 78.5) in the HSQC (heteronuclear single 
quantum correlation) spectrum, that also showed four methyl 
hydrogens at dH 0.82 (s), 0.83 (s), 0.86 (d, J 6.5 Hz) and 
0.96 (d, J 6.5 Hz) correlated to carbons at dC 16.9 (C-18), 
11.4 (C-19), 19.3 (C-27) and 15.8 (C-21), respectively, 
possessing characteristic chemical shifts for steroidal 
alkaloid methyl groups. The signals at dC 78.5 (C-16), 
99.3 (C-22) and 50.2 (C-26) supported a spirosolane-type 
structure.9 Through 2D NMR spectral data [HSQC, HMBC 
(heteronuclear multiple bond correlation) and NOESY 
(nuclear Overhauser effect spectroscopy)], the chemical 
Figure 1. Chemical constituents isolated from the ripe fruits of Solanum 
caavurana.
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shifts of all hydrogens, as well as its correlations, were 
fully established (Table 1).
The 1H NMR spectrum revealed a signal at dH 8.12 
(m, 1H) that was assigned to the formyl hydrogen of 
the formamide group, which existence was previously 
evidenced by HRESIMS analysis, in association with the 
presence of a downfield carbonyl group at dC 160.3. The 
existence of a hydrogen at dH 3.86 and the remaining broad 
low field signal at dH 5.36 (d, 1H, J 7.5 Hz) were assigned 
to H-3 and the formamide N-hydrogen, respectively, by 
analogy with solanopubamide A.10
The NOESY spectrum was used to confirm the proposed 
stereochemistry assignments made for caavuranamide 1 
(Figure 2), as the trans junction of A/B ring and cis 
junction of D/E ring, as well as (25S)-22βN-spirosolane 
configuration (as observed for tomatidine)9 and the 
orientation of 3β-N-formylamino group. A strong NOE 
(nuclear Overhauser effect) was observed between the 
signal of CH3-27 (dH 0.86) with the signal of H-26 (dH 
2.74) and H-24ax (dH 1.37), indicating that CH3-27 is in 
equatorial position. Strong correlations could also be 
observed among CH3-21 (dH 0.96) with H-17 (dH 1.60), 
H-23 (dH 1.66 and 1.34) and H-16 (dH 4.14), suggesting 
Table 1. 1H and 13C NMR spectral dataa for compounds 1-3
Position
1 2 3
dC dH (J in Hz)b dC dH (J in Hz)b dC dH (J in Hz)b
1 32.7 1.02 (m), 1.72 (m) 35.7 1.72 (m), 2.02 (m) 38.5 2.08 (m), 1.38 (m)
2 32.1 1.68 (m), 1.25 (m) 33.9 2.41 (m), 2.44 (m) 38.1 2.11 (m), 2.10 (m)
3 47.6 3.86 (m) 199.6 212.0
4 34.9 1.54 (m) 123.9 5.74 (s) 44.7 2.32 (m), 2.29 (m)
5 45.3 1.18 (m) 171.2 46.7 1.55 (m)
6 28.2 1.21 (m) 32.8 2.36 (m), 2.07 (m) 28.8 1.36 (m), 1.21 (m)
7 32.0 1.68 (m), 0.89 (m) 32.2 1.83 (m), 1.22 (m) 32.7 2.07 (m), 1.30 (m)
8 35.0 1.54 (m) 35.1 1.73 (m) 34.9 1.62 (m)
9 54.7 0.69 (m) 53.8 1.05 (m) 53.9 0.82 (m)
10 36.2 38.7 35.7
11 20.9 1.28 (m), 1.54 (m) 20.8 1.46 (m), 1.54 (m) 21.2 2.11 (m), 1.57 (m)
12 40.2 1.13 (m), 1.71 (m) 39.8 1.16 (m), 1.75 (m) 40.1 1.17 (m), 1.21 (m)
13 40.9 40.7 40.9
14 55.9 1.07 (m) 55.1 1.09 (m) 55.6 1.08 (m)
15 32.6 1.24 (m), 2.00 (m) 32.6 2.40 (m), 2.43 (m) 31.9 1.68 (m), 1.21 (m)
16 78.5 4.14 (m) 78.3 4.16 (q, 7.5) 78.4 4.14 (q, 7.5)
17 62.0 1.60 (m) 61.8 1.68 (m) 61.9 1.55 (m)
18 16.9 0.82 (s) 16.8 0.89 (s) 16.9 0.86 (s)
19 11.4 0.83 (s) 17.4 1.21 (s) 11.5 1.04 (s)
20 42.9 1.66 (m) 43.0 1.66 (m) 43.0 1.74 (m)
21 15.8 0.96 (d, 6.5) 15.9 0.98 (d, 6.5) 15.9 0.98 (d, 6.5)
22 99.3 99.4 99.1
23 26.6 1.66 (m), 1.34 (m) 26.6 1.67 (m), 1.36 (m) 26.6 1.66 (m), 1.37 (m)
24 28.4 1.56 (m), 1.37 (m) 28.5 1.62 (m), 1.33 (m) 28.5 1.64 (m), 1.34 (m)
25 30.9 1.60 (m) 31.0 1.60 (m) 31.0 1.61 (m)
26 50.2 2.74 (m) 50.2 2.71 (m), 2.75 (m) 50.2 2.73 (m), 2.76 (m)
27 19.3 0.86 (d, 6.5) 19.3 0.88 (d, 6.5) 19.3 0.87 (d, 6.5)
CHO 160.3 8.12 (m)
NHCHO 5.36 (d, 7.5)
aExperiments were carried out at 500 MHz for 1H and 125 MHz for 13C in CDCl3 and TMS as internal reference (d 0.00 ppm); bassignments confirmed by 
DEPT-135, HSQC, HMBC and NOESY experiments.
Figure 2. Relevant NOESY correlations observed for caavuranamide (1).
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a S configuration for C-22 and the cis junction of the D/E 
ring. The axial orientation of H-5 (dH 1.18) was sustained 
by intense correlations with H-9ax (dH 0.69) and H-3ax 
(dH 3.86). This later information denotes that the substituent 
N-formylamino located in C-3 is found in 3β arrangement. 
The above findings supported the configuration (25S,22S)-
3β-N-formylamino-5α-spirostane which is in agreement 
with solanopubamide A10 and with data reported for 
(22S,25S)-3β-amino-5α-spirosolane.11
It is known that steroidal alkaloids isolated from the 
Solanaceae possess almost exclusively a 3-hydroxyl 
substituent or its glycosylated derivatives. The only report 
of a N-formyl steroidal alkaloid in the Solanum10 genus 
indicated a solanidane-type skeleton. Caavuranamide 
[(22S,25S)-3β-N-formylamino-5α-spirosolane] (1) is 
the second report of a N-formyl steroidal alkaloid in this 
genus, and the first with a spirosolane-type skeleton.
Compounds 2 and 3 were identified on the basis of 
1H and 13C NMR spectral data (Table 1) as 4-tomatiden-
3-one and 5α-tomatidan-3-one, respectively. Although 
substance 2 has been obtained before by microbial12 
conversion of tomatidine, this is the first report of its 
isolation directly from plants. Compound 3 was previously 
isolated13 from the roots of a hybrid plant between 
Lycopersicon esculentum Mill. and L. hirsutum Humb. et 
Bonpl. (Solanaceae). The 1H and 13C NMR data, as well 
as the assignments of chemical shifts for both compounds, 
were incomplete in the literature, and are now supported 
by DEPT-135 and HSQC experiments.
The crude extracts and fractions obtained from acid-base 
treatment were evaluated for antimicrobial (Table 2) and 
in vitro antiproliferative activities (Table 3). According 
to Table 2, the ethanolic extracts do not show significant 
activity for neither of tested microorganisms, whereas 
CH2Cl2 and n-but extracts, as well as those subfractions 
obtained from acid-base treatment, showed potent activity 
for E. coli, M. luteus, R. equi, B. subtilis and E. faecium, 
being similar and even in some cases, stronger than positive 
control chloramphenicol. Compound 1 (6.6 mg) exhibited 
activity (MIC 135 µmol L-1) similar to chloramphenicol 
Table 2. Antibacterial activity of extracts, fractions and compound 1 of ripe fruits of S. caavurana
Extract and fractions
MIC / (µg mL-1)
Microorganisms
B. subtilis E. coli E. faecium M. luteus P. aeruginosa R. equi S. aureus S. choleraesuis S. epidermides
EtOH extract b b b b b 500 b 700 b
CH2Cl2 fraction 125 125 125 60 b 60 700 600 300
n-But fraction 125 60 125 60 b 60 500 400 250
Neutral CHCl3 fraction 30 60 60 60 b 60 600 400 300
Alkaloid residue 60 60 60 60 b 30 600 200 250
Compounds MIC / (µmol L-1)
Caavuranamide (1) a b a a a 135 1580 b b
Chloramphenicolc 62 124 217 155 2630 124 62 186 0.124
aNot tested; bconcentration > 1000 µg mL-1; cpositive control for bacteria.
Table 3. Antiproliferative activity of extracts and fractions of ripe fruits of S. caavurana against cancer cell lines
Extracts and fractions
TGI / (µg mL-1)
Tumor cell lines
U251 UACC-62 MCF-7 NCI-H460 OVCAR-3 HT-29 786-0 K562 NCI-ADR/RES VERO
EtOH extract b 2.11 93.06 b 84.49 60.90 60.62 b 102.13 b
CH2Cl2 fraction 75.53 b 142.48 b 139.66 115.39 94.97 b b b
n-But fraction 82.45 b 100.40 b 117.84 62.13 46.04 b 243.35 b
Neutral CHCl3 fraction 90.47 8.09 57.17 100.27 100.27 73.67 80.63 b 82.37 b
Alkaloid residue 65.59 37.14 98.21 b 51.77 228.07 74.64 b 61.20 b
Doxorubicina 3.24 0.15 10.49 > 25 5.62 > 25 3.73 > 25 > 25 > 25
aPositive control; bconcentration > 250 mg mL-1; U251 (glioma CNS), UACC-62 (melanoma), MCF-7 (breast), NCI-H460 (lung, non-small cells), 
OVCAR-3 (ovarian), HT-29 (colon), 786-0 (renal), K562 (leukemia), NCI-ADR/RES (ovarian expressing phenotype multiple drugs resistance) and 
VERO (renal, normal cells, green monkey); TGI: concentration (µg mL-1) total growth inhibition.
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(MIC 124 µmol L-1) for R. equi, but it is less active than 
the alkaloid residue that furnished 1.
For in vitro antiproliferative activity, the extracts and 
respective subfractions showed to be active for a wide 
range of human tumor cell lines, with the ethanolic 
extract and neutral CHCl3 fraction presenting the strongest 
antiproliferative results for melanoma (UACC-62) with TGI 
values of 2.11 and 8.09 µg mL-1, respectively.
Conclusions
The present phytochemical investigation of the ripe 
fruits of S. caavurana Vell. afforded a novel steroidal 
alkaloid with spirosolane-type skeleton, named as 
caavuranamide (1), together with the alkaloids 4-tomatiden-
3-one (2) and 5-α-tomatidan-3-one (3). Compound (1) 
showed significant antibacterial activity (MIC 135 mol L-1) 
for R. equi, similar to chloramphenicol (MIC 124 mol L-1).
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